A new opioid developed for the Pentagon could fill drug shortages wrought by the coronavirus — but the FBI says it’s dangerous

There’s a highly potent opioid on the market that you’ve likely never heard of: Dsuvia. This new drug, said to be upwards of 1,000 times more powerful than morphine, was developed with major funding for the Pentagon at a time when the opioid crisis was exploding in the U.S. While AcelRx Pharmaceuticals chief medical officer Pamela Palmer, who led development of Dsuvia, says the drug fills a need both for the military and for hospitals struggling with drug shortages — but critics including the FBI warn that it could lead to even more avoidable deaths.